DocWire News Editors

DocwireNews

Patients with gammopathy of undetermined significance (MGUS) were unable to be classified by bone mineral density (BMD) and trabecular bone score (TBS), according to a study presented at the 17th International Myeloma Workshop.
In this retrospective study, the researchers identified 115 adults diagnosed with MGUS between 2005 and 2018 that had lumbar spine x-rays beginning 24 months prior to MGUS diagnosis. They ascertained MGUS diagnoses using the 2003 IMWG criteria. Subsequently, they matched a control group 1:1 for sex, age, and BMI.  Participants were excluded from the study if they had the presence of primary or metastatic bone malignancy, multiple myeloma (MM), exposure to anti-resorptive or anabolic agents, or exposure to steroids for over three months. TBS values were classified as low (&lt;1.20), intermediate (1.20 – 1.35), or normal (&gt;1.35), and the researchers retrospectively performed TBS analysis using TBS iNsight v3.0 software.
Following data analysis, the results of the study showed that BMD patients had notably higher incident fractures juxtaposed to the control group (14 vs. 7, respectively; P&lt;0.05). The researchers observed no difference between cases and controls as it pertained to the TBS categories (low 23 vs. 15%; intermediate 42 vs. 41%; normal 35 vs. 44%; P=0.22) or LS T-scores (0.30 vs +0.22, P=0.16).
Moreover, although fractures occurred in controls who had a significantly lower TBS value (1.17 vs. 1.34 in controls with vs. without fracture, respectively, P&lt;0.01), the results showed this was not the case in patients with MGUS.
“Despite a significantly increased risk of fractures in patients with MGUS compared to age-, sex- and BMI-matched controls, neither BMD nor TBS, obtained within 2 years of MGUS diagnosis, were able to risk stratify patients,” the research authors wrote. “Indeed, unlike controls, patients with MGUS tend to fracture despite a normal BMD and an intermediate or normal TBS value. More advanced non-invasive measures of bone quality and finite element analysis may be needed to capture this risk.”
Sfeir J, et al. Fracture Risk Assessment in Patients with Monoclonal Gammopathy of Undetermined Significance: Value of Bone Mineral Density and Trabecular Bone Score.
Presented at the 17th International Myeloma Workshop; September 12-15, 2019; Boston, MA.

Jordana Jampel

Effects of Probiotics on QOL, Nutritional Intake in Patients With Crohn Disease

Gastroenterology

Emily Menendez

Suvemcitug Combination Shows Promise in MSS/pMMR Colorectal Cancer

Colorectal Cancer

Genetic Resistance to KRASG12C Inhibitors in CRC and PDAC

Pancreatic Cancer

Latest News

Fracture Risk Assessment in Patients with Monoclonal Gammopathy of Undetermined Significance: Value of Bone Mineral Density and Trabecular Bone Score

International Myeloma Workshop 2019

Patients with gammopathy of undetermined significance (MGUS) were unable to be classified by bone mineral density (BMD) and trabecular bone score (TBS).

Fracture Risk Assessment in Patients with Monoclonal Gammopathy of Undetermined Significance: Value

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe